| Product NDC: | 25021-120 | 
| Proprietary Name: | Cefuroxime | 
| Non Proprietary Name: | cefuroxime sodium | 
| Active Ingredient(s): | 7.5 g/82.5mL & nbsp; cefuroxime sodium | 
| Administration Route(s): | INTRAVENOUS | 
| Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 25021-120 | 
| Labeler Name: | Sagent Pharmaceuticals | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA065046 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20080501 | 
| Package NDC: | 25021-120-59 | 
| Package Description: | 10 VIAL in 1 CARTON (25021-120-59) > 82.5 mL in 1 VIAL | 
| NDC Code | 25021-120-59 | 
| Proprietary Name | Cefuroxime | 
| Package Description | 10 VIAL in 1 CARTON (25021-120-59) > 82.5 mL in 1 VIAL | 
| Product NDC | 25021-120 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | cefuroxime sodium | 
| Dosage Form Name | INJECTION, POWDER, FOR SOLUTION | 
| Route Name | INTRAVENOUS | 
| Start Marketing Date | 20080501 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Sagent Pharmaceuticals | 
| Substance Name | CEFUROXIME SODIUM | 
| Strength Number | 7.5 | 
| Strength Unit | g/82.5mL | 
| Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |